Zobrazeno 1 - 10
of 49
pro vyhledávání: '"KD025"'
Autor:
Megumi Watanabe, Tatsuya Sato, Araya Umetsu, Toshifumi Ogawa, Nami Nishikiori, Megumi Suzuki, Masato Furuhashi, Hiroshi Ohguro
Publikováno v:
Biomedicines, Vol 12, Iss 6, p 1165 (2024)
To investigate the biological significance of Rho-associated coiled-coil-containing protein kinase (ROCK) 2 in the human trabecular meshwork (HTM), changes in both metabolic phenotype and gene expression patterns against a specific ROCK2 inhibitor KD
Externí odkaz:
https://doaj.org/article/510c4eac2fe64ff3b93fe2ab9b804fd2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Adipocyte, Vol 8, Iss 1, Pp 114-124 (2019)
Rho-associated kinases (ROCKs) have been reported to antagonize adipocyte differentiation, and inhibition of ROCKs by small molecules promotes adipogenesis. Surprisingly, our recent study revealed that the ROCK2-specific inhibitor KD025 (SLx-2119), s
Externí odkaz:
https://doaj.org/article/39e39f5cb9c3476aa29a1826041717a1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Molecules, Vol 26, Iss 21, p 6382 (2021)
Effects of a pan-ROCK-inhibitor, ripasudil (Rip), and a ROCK2 inhibitor, KD025 on dexamethasone (DEX)-treated human trabecular meshwork (HTM) cells as a model of steroid-induced glaucoma were investigated. In the presence of Rip or KD025, DEX-treated
Externí odkaz:
https://doaj.org/article/87169559e7f3417f91f53c735e7bf2e0
Autor:
Nhu Nguyen Quynh Tran, Kwang-Hoon Chun
Publikováno v:
Molecules, Vol 26, Iss 16, p 4747 (2021)
KD025, a ROCK2 isoform-specific inhibitor, has an anti-adipogenic activity which is not mediated by ROCK2 inhibition. To identify the target, we searched binding targets of KD025 by using the KINOMEscanTM screening platform, and we identified casein
Externí odkaz:
https://doaj.org/article/3ca41d4db52349b181cb1ee0d0111c41
Publikováno v:
Molecules, Vol 25, Iss 6, p 1369 (2020)
KD025 (SLx-2119), the first specific Rho-associated protein kinase 2 (ROCK2) inhibitor, is a potential new drug candidate currently undergoing several phase 2 clinical trials for psoriasis, idiopathic pulmonary fibrosis, chronic graft-versus-host dis
Externí odkaz:
https://doaj.org/article/27fcb2ec0e874b25b4d8961c8cf3a315
Publikováno v:
Molecules
Volume 26
Issue 21
Molecules, Vol 26, Iss 6382, p 6382 (2021)
Volume 26
Issue 21
Molecules, Vol 26, Iss 6382, p 6382 (2021)
Effects of a pan-ROCK-inhibitor, ripasudil (Rip), and a ROCK2 inhibitor, KD025 on dexamethasone (DEX)-treated human trabecular meshwork (HTM) cells as a model of steroid-induced glaucoma were investigated. In the presence of Rip or KD025, DEX-treated
Autor:
Kwang-Hoon Chun, Nhu Nguyen Quynh Tran
Publikováno v:
Molecules
Volume 26
Issue 16
Molecules, Vol 26, Iss 4747, p 4747 (2021)
Volume 26
Issue 16
Molecules, Vol 26, Iss 4747, p 4747 (2021)
KD025, a ROCK2 isoform-specific inhibitor, has an anti-adipogenic activity which is not mediated by ROCK2 inhibition. To identify the target, we searched binding targets of KD025 by using the KINOMEscanTM screening platform, and we identified casein
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 14
International Journal of Molecular Sciences, Vol 22, Iss 7335, p 7335 (2021)
Volume 22
Issue 14
International Journal of Molecular Sciences, Vol 22, Iss 7335, p 7335 (2021)
Purpose: The effects of Rho-associated coiled-coil containing protein kinase (ROCK) 1 and 2 inhibitor, ripasudil hydrochloride hydrate (Rip), ROCK2 inhibitor, KD025 or rosiglitazone (Rosi) on two-dimension (2D) and three-dimension (3D) cultured human